Latest Period
Q2 2026
Security Snapshot
PDS Biotechnology Corp - Common (PDSB) Institutional Ownership
CUSIP: 70465T107
13F Institutional Holders and Ownership History from Q1 2019 to Q2 2026
Institutions Reporting
51
Shares (Excl. Options)
7,691,925
Price
$0.88
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common
- Symbol
- PDSB on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 7,691,925
- Total 13F value
- $6,775,607
- Portfolio coverage rank
- 0%
- Share change
- +2,711,719
- Value change
- +$2,440,741
- Number of holders
- 51
- Shares outstanding
- 49,594,356
- SEC-reported price per share
- $0.72
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PDSB - PDS Biotechnology Corp - Common is tracked under CUSIP 70465T107.
- 51 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 40 to 51 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $3,053,376 to $6,775,607.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 51 institutions filings for Q2 2026.
Security key
70465T107
Latest holder period
Q2 2026
13F holders
51
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
PDSB full holder history
PDS Biotechnology Corp SEC filings
PDS Biotechnology Corp company facts
PDS Biotechnology Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 70465T107:
As of 30 Jun 2026, 51 institutional investors reported holding 7,691,925 shares of PDS Biotechnology Corp - Common (PDSB). This represents 16% of the company’s total 49,594,356 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
15%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 1,699,315 | +4.2% | 0% | $1,497,097 |
| Focus Partners Wealth | 1.3% | 642,177 | 0% | $565,822 | |
| Quantinno Capital Management LP | 1.3% | 642,177 | 0% | $565,822 | |
| BlackRock, Inc. | 1.2% | 607,639 | +9.7% | 0% | $535,391 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2% | 587,139 | -11% | 0% | $517,410 |
| VANGUARD FIDUCIARY TRUST CO | 0.72% | 357,144 | +16% | 0% | $314,644 |
| Militia Capital Management LLC | 0.67% | 331,800 | 0.05% | $292,349 | |
| CITADEL ADVISORS LLC | 0.65% | 323,801 | 0% | $285,301 | |
| MORGAN STANLEY | 0.63% | 313,922 | +7904% | 0% | $276,597 |
| BLAIR WILLIAM & CO/IL | 0.6% | 300,000 | 0% | 0% | $264,330 |
| JANE STREET GROUP, LLC | 0.56% | 279,664 | 0% | $246,412 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.51% | 252,200 | +14% | 0% | $222,213 |
| INSPIRION WEALTH ADVISORS, LLC | 0.38% | 188,995 | +3.8% | 0.02% | $165,182 |
| MARSHALL WACE, LLP | 0.3% | 147,171 | 0% | $129,510 | |
| STATE STREET CORP | 0.27% | 133,333 | 0% | 0% | $117,480 |
| NORTHERN TRUST CORP | 0.26% | 126,502 | +16% | 0% | $111,461 |
| WELLS FARGO & COMPANY/MN | 0.22% | 109,000 | -1.4% | 0% | $96,040 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.19% | 92,997 | +2.4% | 0% | $81,940 |
| Iron Gate Global Advisors LLC | 0.14% | 70,406 | -6.2% | 0.01% | $62,035 |
| Bank of New York Mellon Corp | 0.14% | 68,491 | -1.2% | 0% | $60,348 |
| Tempus Wealth Planning, LLC | 0.12% | 61,800 | 0% | 0.01% | $54,452 |
| TWO SIGMA SECURITIES, LLC | 0.08% | 41,391 | +31% | 0% | $36,470 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.07% | 36,328 | +65% | 0% | $32,009 |
| RAYMOND JAMES FINANCIAL INC | 0.07% | 33,819 | +230% | 0% | $29,798 |
| XTX Topco Ltd | 0.07% | 33,098 | -8.6% | 0% | $29,163 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
30
Latest
Q2 2026
Rows shown
1-25 of 30
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 7,691,925 | $6,775,607 | +$2,440,741 | $0.88 | 51 |
| 2026 Q1 | 5,047,213 | $3,053,376 | -$1,761,034 | $0.60 | 40 |
| 2025 Q4 | 7,880,577 | $6,066,947 | +$1,624,175 | $0.77 | 43 |
| 2025 Q3 | 5,620,337 | $6,638,921 | -$1,895,965 | $1.01 | 47 |
| 2025 Q2 | 7,451,352 | $9,901,943 | -$1,043,791 | $1.33 | 55 |
| 2025 Q1 | 8,226,452 | $9,789,276 | +$4,484,828 | $1.19 | 46 |
| 2024 Q4 | 4,239,917 | $6,914,602 | -$572,034 | $1.63 | 51 |
| 2024 Q3 | 4,325,988 | $16,519,540 | -$3,544,953 | $3.82 | 56 |
| 2024 Q2 | 5,489,394 | $16,083,121 | -$6,957,012 | $2.93 | 73 |
| 2024 Q1 | 7,611,671 | $30,140,536 | -$4,107,493 | $3.96 | 69 |
| 2023 Q4 | 8,335,087 | $41,487,859 | +$2,355,421 | $4.97 | 74 |
| 2023 Q3 | 7,861,668 | $39,699,832 | -$403,816 | $5.05 | 78 |
| 2023 Q2 | 7,931,948 | $39,898,006 | -$317,214 | $5.03 | 80 |
| 2023 Q1 | 7,611,967 | $46,811,436 | +$1,184,438 | $6.15 | 66 |
| 2022 Q4 | 6,820,799 | $90,031,703 | +$24,029,740 | $13.20 | 63 |
| 2022 Q3 | 5,178,399 | $15,378,000 | -$458,535 | $2.97 | 42 |
| 2022 Q2 | 5,251,472 | $19,171,000 | -$3,835,298 | $3.65 | 46 |
| 2022 Q1 | 5,851,637 | $36,220,000 | -$1,228,374 | $6.19 | 49 |
| 2021 Q4 | 5,916,212 | $47,919,000 | -$12,229,786 | $8.10 | 63 |
| 2021 Q3 | 6,752,518 | $100,597,635 | +$11,330,602 | $14.90 | 58 |
| 2021 Q2 | 5,941,843 | $74,429,183 | +$40,638,979 | $12.55 | 41 |
| 2021 Q1 | 3,145,310 | $14,311,158 | +$1,348,464 | $4.55 | 29 |
| 2020 Q4 | 3,132,654 | $6,703,955 | -$487,455 | $2.14 | 25 |
| 2020 Q3 | 3,298,108 | $7,682,631 | +$3,730,298 | $2.33 | 27 |
| 2020 Q2 | 1,702,221 | $3,419,000 | +$619,479 | $2.01 | 18 |